Patents by Inventor Robin Pettit

Robin Pettit has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050014849
    Abstract: The antifungal and cancer cell growth inhibitory activities of 1-(3?,4?,5?-trimethoxyphenyl)-2-nitro-ethylene (TMPN) were examined. TMPN was fungicidal for the majority of 132 reference strains and clinical isolates tested, including those resistant to fluconazole, ketoconazole, amphotericin B or flucytosine. Minimum fungicidal concentration/minimum inhibitory concentration (MFC/MIC) ratios were ?2 for 96% of Cryptococcus neoformans clinical isolates and 71% of Candida albicans clinical isolates. TMPN was fungicidal for a variety of other basidiomycetes, endomycetes and hyphomycetes, and its activity was unaffected by alterations in media pH. TMPN was slightly cytotoxic for murine and human cancer cell lines (GI50=1-4 ?g/ml), and weakly inhibited mammalian tubulin polymerization (IC50=0.60 ?g/ml). TMPN may also be used as a biochemical probe for tubulin and fungal dimorphism studies.
    Type: Application
    Filed: December 20, 2002
    Publication date: January 20, 2005
    Inventors: George Pettit, Robin Pettit